Bone health assessment with dual energy X-ray absorptiometry in men with high-risk prostate carcinoma commencing adjuvant androgen deprivation therapy.

Pan, Belinda; Aherne, Noel J; Shakespeare, Thomas P; Grossmann, Mathis; Wong, Peter K K

Pan, Belinda; Aherne, Noel J; Shakespeare, Thomas P; Grossmann, Mathis; Wong, Peter K K.

Afiliación

Pan B; Department of Medicine, Coffs Harbour Health Campus, New South Wales, Australia.
Aherne NJ; Department of Radiation Oncology, Mid-North Coast Cancer Institute, Coffs Harbour, New South Wales, Australia.
Shakespeare TP; School of Health and Human Sciences, Southern Cross University, New South Wales, Australia.
Grossmann M; Rural Clinical School Faculty of Medicine, University of New South Wales, New South Wales, Australia.
Wong PKK; Department of Radiation Oncology, Mid-North Coast Cancer Institute, Coffs Harbour, New South Wales, Australia.

Rep Pract Oncol Radiother ; 27(4): 677-683, 2022.

Article en En | MEDLINE | ID: mdl-36196418

Palabras clave

DXA; androgen deprivation; bone density; osteoporosis; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Rep Pract Oncol Radiother Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google